Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)

India · Delayed Price · Currency is INR

32.65

+0.67 (2.10%)

At close: Jul 27, 2026

-27.77% (1Y)

Market Cap	527.27M -28.3%
Revenue (ttm)	314.78M -6.3%
Net Income	27.86M +399.6%
EPS	1.71 +402.9%
Shares Out	16.27M
PE Ratio	18.95
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	544
Open	33.00
Previous Close	31.98
Day's Range	32.05 - 33.18
52-Week Range	25.60 - 46.82
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About BOM:524396

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Phar... [Read more]

Industry Pharmaceutical Preparations

Founded 1985

Employees 26

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524396

Full Company Profile

Financial Performance

In fiscal year 2026, BOM:524396's revenue was 314.78 million, a decrease of -6.27% compared to the previous year's 335.82 million. Earnings were 27.86 million, an increase of 399.55%.

Financial Statements